Håndtering af amlodipinudløste ankelødemer

Translated title of the contribution: Management of amlodipine-induced ankle oedema

Birgit K. Skovbjerg*, Ole Møller-Helgestad, Christina Stolzenburg Oxlund, Bo Christensen, Jakob N Henriksen

*Corresponding author for this work

Research output: Contribution to journalJournal articleResearchpeer-review

233 Downloads (Pure)

Abstract

Pedal oedema is a well-known adverse effect of amlodipine, but significantly less frequent if only half of the maximum recommended dosage is used. Diuretics are ineffective. To cause as few side effects as possible, options for managing are prioritised in this review: Reduce dosage, switch to lercanidipine/lacidipine, switch to another group, add/increase dosage of an ACE-inhibitor/angiotensin II-receptor blocker, administer at night, or switch to verapamil/diltiazem. Non-pharmacologic actions or observation may be considered when the oedemas are mild and not bothersome.
Translated title of the contributionManagement of amlodipine-induced ankle oedema
Original languageDanish
Article numberV07220460
JournalUgeskrift for Læger
Volume185
Issue number17
Pages (from-to)1601-1603
ISSN0041-5782
Publication statusPublished - 4. Sept 2023

Fingerprint

Dive into the research topics of 'Management of amlodipine-induced ankle oedema'. Together they form a unique fingerprint.

Cite this